Digoxin Use in Cardiac Amyloidosis

We present our experience with digoxin use in patients with CA and report the event rate of suspected digoxin-related arrhythmias and toxicity. This is a retrospective study of patients with CA seen at our institution between November 1995 and October 2018. Patients were screened for a history of ≥7 days of continuous digoxin use and stratified based on amyloid precursor protein – transthyretin (ATTR) and immunoglobulin light chain (AL).

Source: The American Journal of Cardiology - July 22, 2020 Category: Cardiology Authors: Joseph P. Donnelly, Brett W. Sperry, Andrej Gabrovsek, Asad Ikram, W.H. Wilson Tang, Jerry Estep, Mazen Hanna Source Type: research